These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1468768)

  • 1. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors.
    Serra M; Morini MC; Scotlandi K; Fisher LW; Zini N; Colombo MP; Campanacci M; Maraldi NM; Olivari S; Baldini N
    Hum Pathol; 1992 Dec; 23(12):1326-31. PubMed ID: 1468768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonectin in osteosarcomas: a marker for differential diagnosis and/or prognosis?
    Wuisman P; Roessner A; Bosse A; Ueda Y; Winkelmann W; Enneking WF
    Ann Oncol; 1992 Apr; 3 Suppl 2():S33-5. PubMed ID: 1622861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
    Devaney K; Vinh TN; Sweet DE
    Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenic tumors of bone.
    Green JT; Mills AM
    Semin Diagn Pathol; 2014 Jan; 31(1):21-9. PubMed ID: 24680179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current trends in the diagnosis and treatment of malignant bone tumors.
    Schajowicz F
    Clin Orthop Relat Res; 1983 Nov; (180):220-52. PubMed ID: 6313271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone-Forming Tumors.
    Zhang Y; Rosenberg AE
    Surg Pathol Clin; 2017 Sep; 10(3):513-535. PubMed ID: 28797500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
    Park YK; Yang MH; Park HR
    Skeletal Radiol; 1996 Jan; 25(1):13-7. PubMed ID: 8717113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoid-producing tumors of bone.
    White LM; Kandel R
    Semin Musculoskelet Radiol; 2000; 4(1):25-43. PubMed ID: 11061690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
    Amary F; Markert E; Berisha F; Ye H; Gerrand C; Cool P; Tirabosco R; Lindsay D; Pillay N; O'Donnell P; Baumhoer D; Flanagan AM
    Am J Surg Pathol; 2019 Dec; 43(12):1661-1667. PubMed ID: 31490237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
    Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
    Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metacarpal giant cell tumor, a sternal osteoblastoma and a pubic osteogenic sarcoma in the same patient.
    Roberts A; Long J; Wickstrom J
    South Med J; 1976 May; 69(5):660-2. PubMed ID: 1064178
    [No Abstract]   [Full Text] [Related]  

  • 12. Fine needle aspiration of bone tumors.
    Agarwal S; Agarwal T; Agarwal R; Agarwal PK; Jain UK
    Cancer Detect Prev; 2000; 24(6):602-9. PubMed ID: 11198274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
    Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J
    Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma.
    Lam SW; Cleven AHG; Kroon HM; Briaire-de Bruijn IH; Szuhai K; Bovée JVMG
    Virchows Arch; 2020 Mar; 476(3):455-463. PubMed ID: 31768625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic difficulties in skeletal pathology.
    Schajowicz F; McGuire MH
    Clin Orthop Relat Res; 1989 Mar; (240):281-310. PubMed ID: 2537165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects of bone tumors].
    Betzler M
    Aktuelle Probl Chir Orthop; 1977; 5():10-25. PubMed ID: 22262
    [No Abstract]   [Full Text] [Related]  

  • 18. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
    Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
    Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteosarcoma resembling osteoblastoma.
    Bertoni F; Unni KK; McLeod RA; Dahlin DC
    Cancer; 1985 Jan; 55(2):416-26. PubMed ID: 3855268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma.
    Fanburg JC; Rosenberg AE; Weaver DL; Leslie KO; Mann KG; Taatjes DJ; Tracy RP
    Am J Clin Pathol; 1997 Oct; 108(4):464-73. PubMed ID: 9322601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.